Redressing the balance can start from the bottom up.
Just about everyone wants medical care, but some want it a lot more. We discovered a personality trait that explains why it's hard to improve health care outcomes and costs.
Trump cuts bait, Ryan loses his nerve – and the Obamacare repeal goes down without a vote. What's next for Congress and the GOP?
Spiralling living costs on a diminshed pension has come with uncertainty about the future.
In preparing the 2017 national budget South Africa needs to take heed of warnings that its historical austerity measures are hurting the poor and even costing lives.
In twin speeches to the National Press Club, Labor leader Bill Shorten said bulk-billing rates are falling, while Prime Minister Malcolm Turnbull said bulk-billing is at record levels. Who was right?
Doctors in Kenya went on strike two months ago asking the government to implement a collective bargaining agreement signed in June 2013.
Kenya faces a rising number of major incidents and disasters. Any delays in treating patients could result in increased morbidity and mortality rates.
With more demand on doctors and nurses and a push for quicker consultations, clinical empathy is being dwarfed by the need for efficiency.
Artificial intelligence is already transforming a range of industries but it has still to make an impact on healthcare. So what's the hold up?
The difficulties that soldiers face when returning home from battle are part of an old, old story.
An American who trained to be a doctor in Cuba gives his views of the island's health service.
Most healthcare information is written at a level more advanced than the reader's ability.
The burden of an ageing population on health systems is only going to grow, in both rich and poor countries.
Unless the government matches spending by other Western governments, the health service will fail.
Shadow minister for health and medicare Catherine King said under this government, average out-of-pocket costs for GP visits are up by almost 20%. Is that true?
A new study has advanced the use of a technique known as 'CRISPR' to treat a common inherited form of anaemia.
Trials into the effectiveness of drugs and treatments struggle to recruit enough participants, yet we rely on their results anyway.
Why drug maker Mylan's decision to introduce a half-price version of its EpiPen could be more than a publicity stunt.
Harsh tales of mothers and fathers thrust into the court system as they seek the best treatment for a sick child are a warning.